# Study to Investigate Efficacy and Safety of a New Oral Contraceptive

> **NCT00185289** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 1392 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** EV/DNG (Qlaira, BAY86-5027, SH T00658K)

## Key facts

- **NCT ID:** NCT00185289
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 1392 (ACTUAL)
- **Last updated:** 2011-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185289, "Study to Investigate Efficacy and Safety of a New Oral Contraceptive". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00185289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*